Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
PharmaLex Denmark A/S
A/S
Active
CVR 18652439
Lyngby Hovedgade 10C, 2800
Kongens Lyngby
Business and other management consultancy activities
·
NACE 7020
Est. 1995 · 30 years old
17 employees
Overvåg
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
PharmaLex Denmark A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
9M
17M
26M
35M
23M
2021
30M
2022
21M
2023
26M
2024
17M
2025
EBITDA
DKK millions
9M
6M
3M
0M
-3M
3M
2021
7M
+133%
2022
2M
-71%
2023
2M
0%
2024
-2M
-200%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
22.718
29.957
20.503
26.015
17.235
Staff expenses
-19.354
-22.473
-18.828
-23.657
-19.311
EBITDA
3.364
7.484
1.674
2.359
-2.076
Depreciation & amort.
-112
-91
-68
-107
-91
EBIT
3.252
7.393
1.606
2.251
-2.167
Net financials
125
-87
-11
-16
-32
Profit before tax
3.377
7.305
1.595
2.235
-2.199
Tax
743
1.525
351
489
-487
Net profit
2.634
5.780
1.244
1.746
-1.712
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
11.309
12.896
13.125
12.543
18.307
Equity
3.853
6.583
5.228
5.973
2.761
Long-term debt
0
0
0
0
8.000
Short-term debt
7.456
6.313
7.898
6.570
7.546
Total debt
7.456
6.313
7.898
6.570
15.546
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-12.0%
This company
2021
2025
Soliditetsgrad
15.1%
This company
38.2%
Market median
-60% vs market
2021
2025
Egenkapitalforrentning
-62.0%
This company
18.4%
Market median
-437% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
-9.9%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
0.94×
This company
2021
2025
Gæld/egenkapital
5.63×
This company
0.62×
Market median
-808% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on PharmaLex Denmark A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
